In heart failure, the release of calcium becomes erratic leading to the generation of arrhythmias. Dysregulated Zn 2ϩ homeostasis occurs in chronic heart failure. 
Aberrant
In cardiac muscle, the intracellular signal that triggers muscle contraction is thought to be a transient rise in intracellular Ca 2ϩ that leads to the opening of Ca 2ϩ release channels called type 2 ryanodine receptors (RyR2) 2 on the sarcoplasmic reticulum (SR). The resulting release of Ca 2ϩ into the cytosol causes movement of contractile myofibrils leading to cell contraction. Damaging changes in Ca 2ϩ homeostasis are associated with heart failure, conduction abnormalities, and contractile dysfunction. Abnormal RyR2 function is recognized as an important component in the etiology of such disease states (1) (2) (3) .
Recently, there has been much interest in the role of Zn 2ϩ as an intracellular signaling molecule (4 -6) . Like Ca 2ϩ , intracellular Zn 2ϩ is heavily buffered (7) , and cellular Zn 2ϩ homeostasis requires mechanisms that tightly control the uptake, storage, and distribution of Zn 2ϩ . This is achieved through the coordinated actions of metallothionein proteins and Zn 2ϩ transporters (8 -10) .
In cardiomyocytes, the resting intracellular Zn 2ϩ concentration is reported to be at picomolar levels (ϳ100 pM) (11, 12) . During cardiac excitation-contraction coupling, intracellular Zn 2ϩ concentrations are altered, and spatiotemporal fluctuations in free Zn 2ϩ levels, including both Zn 2ϩ transients and Zn 2ϩ sparks, are suggested to be remarkably similar to those previously shown for Ca 2ϩ (13) . Other groups suggest that Zn 2ϩ can permeate through the L-type channel with a greater affinity than Ca 2ϩ but with a much lower permeability leading to a reduction in the inward current (14, 15) . It has also been suggested that the SR can function as an intracellular store for Zn 2ϩ alongside Ca 2ϩ (6, 13) . Importantly aberrant Zn 2ϩ homeostasis has been shown to be associated with cardiomyopathy including chronic heart failure, and myocardial damage as a result of dysregulated intracellular Ca 2ϩ release, reduced cardiac contractility, and significantly prolonged rises of systolic Ca 2ϩ (16 -19) . The potential role of Zn 2ϩ in shaping intracellular Ca 2ϩ release and regulating intracellular Ca 2ϩ dynamics in heart however, is poorly characterized. Here we show that Zn 2ϩ is a potent regulator of SR Ca 2ϩ release through modulation of RyR2 channel function and that Zn 2ϩ plays a key role in shaping intracellular Ca 2ϩ dynamics important in cardiac excitation-contraction coupling.
Experimental Procedures
Reagents-Chemicals were AnalaR or the best equivalent grade from BDH Chemicals (Poole, UK) or Sigma-Aldrich. All solutions were made in deionized water, and those for use in bilayer experiments were filtered through a Millipore membrane filter (0.45-m pore). 2,2Ј-(Ethylenedioxy)dianiline-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) (Dorset, UK) and N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) were from Sigma-Aldrich.
SR Vesicle Preparation and Planar Phospholipid Bilayer Techniques-Sheep hearts were obtained from a local abattoir, and heavy SR membrane vesicles were prepared and fused with planar phosphatidylethanolamine lipid bilayers, as described previously (20) . Briefly, heavy SR vesicles were prepared as follows. Homogenized ventricular cardiac tissue from sheep was subjected to centrifugation at 6,500 ϫ g followed by ultracentrifugation of the supernatant at 100,000 ϫ g. The heavy SR membrane fraction was obtained from loading mixed membranes onto a discontinuous sucrose density gradient. Heavy SR was collected, snap frozen in liquid N 2 , and stored at Ϫ80°C. As reported previously, SR vesicles fused in a fixed orientation such that the cis-chamber corresponded to the cytosolic face of the channel and the trans-chamber to the SR lumen (21, 22) . The trans-chamber was held at ground and the cis-chamber at potentials relative to ground. After fusion, the cis-chamber was perfused with 250 mM HEPES, 80 mM Tris, and 10 M free Ca 2ϩ (pH 7.2). The trans-chamber was perfused with 250 mM glutamic acid and 10 mM HEPES (pH to 7.2) with Ca(OH) 2 (concentration of free Ca 2ϩ ϳ50 mM). The identity of RyR2 was confirmed by the single-channel conductance, and the number of channels gating in the bilayer was assessed by the application of caffeine at the end of the experiment. Zn 2ϩ was added as ZnCl 2 to the cis-chamber at the required concentration from an appropriate stock solution. 100 mM stock solution of ZnCl 2 was prepared in 0.029 M HCl, and serial ZnCl 2 dilutions were made in a Tris/HEPES buffer which contained, 250 mM HEPES, 80 mM Tris, and 10 M free Ca 2ϩ (pH 7.2) to make appropriate stock solutions. The concentration of each Zn 2ϩ stock was further assessed using a pZn meter (Neurobiotex.com, Galveston, TX) as previously described (23) to confirm the accuracy of our serial dilutions. The lowest concentration Zn 2ϩ stock made was 10 nM. The addition of 100 M ZnCl 2 to our Tris/HEPES buffer had no significant effect on the pH (pH was 7.22 Ϯ 0.014 before and 7.21 Ϯ 0.016 after the addition of 100 M ZnCl 2 ; n ϭ 3) . Special care was taken when preparing Zn 2ϩ stock solutions. All glassware was prewashed with 100 nM TPEN and then rinsed carefully with MilliQ water passed through a Chelex Resin (Bio-Rad). The use of colored pipette tips was also avoided.
Experiments were carried out at room temperature (22 Ϯ 2°C). The concentration of free Ca 2ϩ and pH of all of our solutions were determined using a Ca 2ϩ electrode and a pH electrode (Hanna Instruments, Bedfordshire, UK) as previously described (20) . Our measurements showed that the addition of Zn 2ϩ Յ 100 M had no significant effect on the concentration of free Ca 2ϩ ([Ca 2ϩ ] was 10 Ϯ 3.8 M in the absence of Zn 2ϩ and 10 Ϯ 3.2 M in the presence of 100 M Zn 2ϩ (n ϭ 3). The addition of 1 mM BAPTA reduced the free Ca 2ϩ concentration from 10 Ϯ 2 M to 10 Ϯ 3.8 nM (n ϭ 3). Subsequent addition of ZnCl 2 (Յ100 M) had no significant effect on the measured free Ca 2ϩ concentration (10 Ϯ 3.2 nM; n ϭ 3) under these conditions. The total concentration of Zn 2ϩ in all of our recording solutions was assessed using inductively coupled plasma optical emission spectrometry (ICP-OES) (University of Edinburgh, Grant Institute, commercial facility) and shown to be below the detectable limit (1 ppb). Free Zn 2ϩ was also assessed using a pZn meter and calculated to be ϳ9 pM. The addition of concentrations of Ca 2ϩ Յ 100 M had no significant effect on the concentration of free Zn 2ϩ ([Zn 2ϩ ] was 9 Ϯ 7 pM in the presence of 10 M Ca 2ϩ and 10 Ϯ 6 pM when Ca 2ϩ was raised to 100 M; n ϭ 3). The calculated free Zn 2ϩ concentration following addition of 1 mM cytosolic BAPTA was first estimated using the MaxChelator program and then assessed by actual measurements of free Zn 2ϩ using a pZn meter. When the starting free Ca 2ϩ concentration was 10 M, the addition of 1 mM BAPTA had no significant effect on free Zn 2ϩ levels. Single Channel Recording and Analysis-Single-channel currents were monitored under voltage-clamp conditions using a BC-525C amplifier (Warner Instruments, Harvard Instruments). Channel recordings were low pass filtered at 10 kHz with a 4-pole Bessel filter, digitized at 100 kHz using a National Instruments acquisition interface (NIDAQ-MX; National Instruments, Austin, TX), and recorded on a computer hard drive using WinEDR 3.05 software (John Dempster, University of Strathclyde, Glasgow, UK). The recordings were subsequently filtered at 800 Hz (Ϫ3 dB) using a low pass digital filter implemented in WinEDR 3.05. Channel events were detected by the 50% threshold method (24) using TAC 4.2.0 software (Bruxton Corporation, Seattle, WA). Open probability (P o ) and lifetime distributions were calculated from 3 min of continuous recording using TACfit 4.2.0 software (Bruxton Corporation). Lifetime analysis was carried out only when a single channel was incorporated into the bilayer. Individual lifetimes were fitted to a probability density function using the method of maximum likelihood (24) . Lifetimes of Ͻ1 ms were not fully resolved under the conditions of data acquisition described here and were therefore excluded from the fitting procedure. A missed events correction was applied as previously described (25) . Ca 2ϩ Waves-Adult male Wistar rats (300 -400 g) were killed by concussion followed by cervical dislocation. The care and sacrifice of the animals conformed to the requirements of Directive 2010/63/EU of the European Parliament.
Isolation of Cardiomyocytes-All extracellular solutions were based on a modified Tyrode's solution. The basic solution contained, 135 mM NaCl, 5 mM KCl, 330 M NaH 2 PO 4 , 5 mM glucose, 5 mM sodium pyruvate, 10 mM HEPES, 1 mM MgCl 2 , and 2 mM CaCl 2 (pH 7.4). Nominally Ca 2ϩ -free Tyrode's solution used during cardiomyocyte isolation was as outlined above with no added Ca 2ϩ . The protocol for isolation of cardiomyocytes was as described previously (26) . Briefly, the whole heart was rapidly excised and placed into cold, nominally Ca 2ϩ -free Tyrode's solution (NT). The heart was then cannulated via the aorta on a Langendorff type apparatus and warmed NT buffer at 37°C was perfused through the heart in a retrograde fashion for 6 min to clear residual blood. The solution was then exchanged for a Ca 2ϩ -free NT buffer with enzyme mix (containing 15 mg of collagenase type II (Worthington), with 50 mg of bovine serum albumin prepared from Cohn fraction V albumin and 18 mg of protease (type XIV 15% Ca 2ϩ ) in 30 ml) for 8 -15 min. Identification of rod-shaped cardiomyocytes in the perfusate was used as an indication of digestion being complete. The solution was then exchanged for a 2 mM Ca 2ϩ NT solution, the heart was cut down, and cardiomyocytes were mechanically dispersed from the tissue in a shaking water bath. Typically this method yielded 70 -90% rod-shaped cardiomyocytes, which were stored in NT solution at room temperature and used within 18 h of isolating. In intact myocytes, cells were exposed to ZnCl 2 in the presence of the zinc ionophore, zinc pyrithione (ZnPy) to enable the entry of Zn 2ϩ into the cell because ZnCl 2 is cell-impermeable.
Cell Permeabilization-Isolated cardiomyocytes were permeabilized using saponin. Briefly, cardiomyocytes were perfused with 0.5 mM Ca 2ϩ Tyrode's solution for 2 min prior to perfusion with a solution containing 100 M EGTA, 5 mM ATP, 10 mM HEPES, 150 mM potassium gluconate, 25 M MgCl 2 at 20°C. The sarcolemmal membrane was permeabilized with saponin (50 g/ml) for 30 s. After permeabilization, cardiomyocytes were maintained in recording solution containing 1 mM EGTA, 10 mM HEPES, 120 mM potassium gluconate, 5 mM ATP, 1 mM pyruvate, 1 mM free MgCl 2 , and 100 nM free Ca 2ϩ (calculated using the MaxChelator program), and 30 M Fluo-4, pH 7.2. 1 mM BAPTA was added as indicated in the text, and additional Zn 2ϩ was added to maintain as required. Imaging-Images from permeabilized cardiomyoyctes were recorded using an Olympus 1X81 confocal microscope system using Olympus Fluoview software (version 4.0). Line scans were recorded using a 60ϫ oil immersion lens using 2 ϫ 2 pixel binning where each pixel was 0.43 m in diameter. Fluo-4 indicator was excited using a 488-nm laser, and line scans were acquired at a rate of 333 Hz. The data were analyzed offline using ImageJ software. In our Tyrode's solution alone, in the presence of 100 nM Ca 2ϩ , there was no significant change in Fluo-4 fluorescence with increasing concentrations of Zn 2ϩ (⌬Fluo-4 F/F 0 0.026 Ϯ 0.01 units in 10 nM Zn 2ϩ compared with control Tyrode's solution with no ZnCl 2 added). For the cardiomyocyte experiments, ZnCl 2 stocks were made directly in Tyrode's solution because the maximum concentration of Zn 2ϩ used was 100 nM. For measurements of Ca 2ϩ or Zn 2ϩ in intact cardiomyocytes using Fluo-4-AM or Zinpyr-1, cells were illuminated with 488 nm using a monochromator (Photon Technology International, Birmingham, NJ) with fluorescence emissions captured above 520 nm using a Cascade 512B CCD camera (Photometrics, Tuscan, AZ) and continuously perfused Statistics-The data were expressed as means Ϯ S.E. Where appropriate, a Student's t test was used to assess the difference between mean values. A p value of 0.05 was taken as significant. Where multiple treatments were compared, ANOVA followed by a Bonferroni post hoc test was used to assess the difference between treatments. A p value of 0.05 was taken as significant.
Results

Effect of Zn
2ϩ on RyR2 Function-To determine whether Zn 2ϩ can alter RyR2 gating, single RyR2 channels were incorporated into phospholipid bilayers enabling the membrane environment to be carefully controlled, and the direct action of Zn 2ϩ at the cytosolic face of the channel was studied. Using Ca 2ϩ as a permeant ion and holding at a command potential of 0 mV, which is considered to be the resting membrane potential of the sarcoplasmic reticulum (27) , the addition of 100 pM Zn 2ϩ to the cytosolic face of RyR2 channels significantly increased (Fig. 1) , indicating that RyR2 has high affinity for Zn 2ϩ . The potentiation of RyR2 gating by physiological concentrations of free Zn 2ϩ suggests that the amount of Ca 2ϩ released through a single RyR2 channel following activation by cytosolic Ca 2ϩ is significantly greater than previously thought. When Zn 2ϩ levels were incremented in a cumulative fashion, channel activation plateaued at 1 nM Zn 2ϩ , and higher concentrations of Zn 2ϩ (Ͼ10 nM) had no further significant effect on channel P o (Fig. 1B) . Physiological concentrations of Zn 2ϩ will therefore play a key role in regulating graded Ca 2ϩ release events via RyR2 channels, enabling flexibility in the force of cardiac contraction, permitting the heart to adjust to altered diastolic filling (28) . The addition of 1 mM Zn 2ϩ to the cytosolic face of RyR2 completely abolished all channel openings (Fig. 1, A and B) , possibly a consequence of Zn 2ϩ binding to the low affinity divalent inhibitory site of RyR2 (29) . Control HCl buffer solution containing no Zn 2ϩ had no significant effect on RyR2 gating (Fig. 2A ). To confirm that the level of free Zn 2ϩ in our recording solutions, which was measured at ϳ9 pM, was insufficient to influence channel gating, we exposed RyR2 channels to the potent Zn 2ϩ chelator TPEN. In the absence of exogenously added Zn 2ϩ , the addition of 100 nM TPEN to the cis-chamber caused no significant change in channel P o (Fig. 2B) .
Mechanisms (Fig. 1C) . Control channel-gating was best characterized by short openings and long closing as described previously (30, 31) . The addition of Zn 2ϩ in the concentration range 100 pM to 10 nM appeared to sensitize RyR2 to cytosolic Ca 2ϩ , revealed by a reduction in the duration of all the closed states with little effect on the duration of channel openings (32) . When the free Zn 2ϩ concentration was elevated to Ͼ1 nM, RyR2 dwelled for longer sojourns in the open state and displayed briefer sojourns in the closed state (see Table 1 for average lifetime data). This type of gating is characteristic of Ca 2ϩ -independent channel openings (21) .
It is clear from the presented data that activating Zn 2ϩ -binding sites exist on the cytosolic face of RyR2. To assess whether Zn 2ϩ binds to the same cytosolic activation sites on RyR2 as Ca 2ϩ , we first exposed RyR2 to a concentration of cytosolic Ca 2ϩ known to elevate P o to peak levels (100 M) (30) and then added subsequent cumulative doses of Zn 2ϩ to the cytosolic face of the channel (Fig. 3 ). In the presence of 100 M cytosolic Ca 2ϩ and using Ca 2ϩ as permeant ion, subsequent addition of cytosolic Zn 2ϩ in the range 1 nM to 100 M had no significant effect on RyR2 P o . Lifetime analysis, however, showed that at concentrations of Zn 2ϩ Ͼ 1 nM channel gating was altered, and the channel dwelled in longer-lived open states, consistent with Ca 2ϩ -independent channel openings (21) . These data suggest that at least some of the Zn 2ϩ -binding sites are distinct from the Ca 2ϩ -binding sites. Irrespective of whether the concentration of cytosolic Ca 2ϩ was 10 or 100 M, the addition of 1 mM cytosolic Zn 2ϩ was always found to abolish channel openings. This suggests that in addition to high affinity Zn 2ϩ activation sites, RyR2 also has low affinity Zn 2ϩ inhibition sites. We next examined the interplay between Zn 2ϩ and Ca 2ϩ at the cytoplasmic face of RyR2 (Fig. 4) . Using Ca 2ϩ as permeant ion and holding at a command potential of 0 mV, when the free Ca 2ϩ was reduced to a subactivating concentration (Ͻ10 nM) by the addition of 1 mM BAPTA, as expected, the P o value for RyR2 reduced to zero (31) . The subsequent addition of 1 nM Zn 2ϩ to the cytosolic face of the channel had no effect on P o , and the channel remained closed because under these conditions, channel gating is dependent on activation by cytosolic Ca 2ϩ . The subsequent addition of Zn 2ϩ in the range 100 nM to 100 M, however, resulted in channel activations. This is important because RyR2 is now gating in a Ca 2ϩ -independent manner, whereby Zn 2ϩ is the sole activating ligand and the need for Ca 2ϩ to activate the channel is removed.
Effects of Cytosolic Zn
2ϩ on Calcium Waves in Cardiac Cells-We then measured the effect of Zn 2ϩ on Ca 2ϩ waves recorded in isolated cardiomyocytes to provide evidence for the modulation of RyR2 function by Zn 2ϩ in a cellular environment (Fig. 5) . In these experiments, cardiomyocytes were permeabilized to allow the intracellular concentration of Zn 2ϩ to be controlled, and Ca 2ϩ fluorescence measurements were made using Fluo-4. In control recording conditions, where cardiomyocytes were perfused with an intracellular solution containing 100 nM free Ca 2ϩ , there were no appreciable change in Ca 2ϩ release from the intracellular stores. Perfusion with increasing concentrations of Zn 2ϩ (between 100 pM and 10 nM Zn 2ϩ ), however, caused a marked increase in both the incidence of spontaneous Ca 2ϩ waves and the amplitude of these events in a Zn 2ϩ concentration-dependent manner (Fig. 5C ). Increasing the Zn 2ϩ concentration to Ͼ100 nM caused a marked decrease in the amplitude and frequency of waves, and the cardiomyocytes entered an irreversible series of Ca 2ϩ waves often culminating in hypercontracture resulting in a loss of membrane integrity. This concentration of Zn 2ϩ is close to the pathophysiological concentration of Zn 2ϩ previously reported (ϳ30 nM) (33) (34) (35) (36) (Fig. 6 ), presumably as a result of substantial Ca 2ϩ buffering. We next examined the caffeine-induced release of SR Ca 2ϩ in intact cardiomyocytes in the presence and absence of the ZnPy in Tyrode's solution containing 100 pM Zn 2ϩ (Fig. 7) . The increase in Fluo-4 fluorescence on application of 5 mM caffeine was markedly potentiated by treatment with 10 M ZnPy, suggesting that the increase in intracellular (Fig. 8, A and  B) , and a concomitant increase in intracellular Zn 2ϩ measured using the fluorescent indicator Zinpyr-1 (Fig. 8, C and D) . As shown by edge detection measurements, this resulted in spontaneous contractions compared with control cells (Fig. 9, A and B) . The observed spontaneous contractions were reversed by chelating intracellular Zn 2ϩ by the addition of 10 M TPEN (Fig. 9, C and  D) , confirming that these cellular effects are attributed to elevated intracellular Zn 2ϩ levels.
Discussion
In this study, we reveal that cytosolic Zn 2ϩ is a high affinity activator of RyR2, effective at low picomolar concentrations. (41) . This is not surprising because our data now reveal that in the presence of peak levels of Ca 2ϩ , the effect of Zn 2ϩ on channel P o is masked. Only by lifetime analysis of our single channel data could we reveal that the mode of chan- (29, 45) .
Aberrant Zn 2ϩ homeostasis has been shown to be associated with cardiomyopathy (46 -48) , but the underlying mechanism of how Zn 2ϩ contributes to cardiac pathology is unknown. Chronic oxidative stress is a major contributor in the pathophysiology of heart failure and under these conditions intracellular levels of Zn 2ϩ increase by as much as 30-fold (36) . This increase in Zn 2ϩ is primarily the result of altered metallothionein function, which perturbs its binding of Zn 2ϩ , resulting in raised levels (49, 50) . Also, recently, a polymorphism in a human gene coding for a member of the metallothionein family has been discovered, and individuals with diabetes who carry this polymorphism have been shown to be more likely to develop cardiovascular complications including chronic heart failure and myocardial damage (51) . Diabetic cardiomyopathy is characterized by dysregulation of intracellular Ca 2ϩ release, which consequently reduces cardiac contractility and significantly prolongs the rise of systolic Ca 2ϩ leading to chronic heart failure (16) . The controlled release of Ca 2ϩ from the SR during cardiac excitation-contraction coupling is known to govern contractility of the heart. RyR2 plays a fundamental role as the main pathway for the release of Ca 2ϩ and drives cellular contraction. Consequently dysfunction in the release of Ca 2ϩ and modulatory influences that control RyR2 function are identified as contributory to the pathophysiology of heart failure and fatal cardiac arrhythmias (1) . The presented study therefore provides a mechanistic explanation as to how raised levels of intracellular Zn 2ϩ may contribute to the progression of contractile dysfunction and heart failure through the alteration of RyR2 gating, which will result in perturbed Ca 2ϩ release. A simple model to explain how cytosolic Zn 2ϩ modulates RyR2 gating is shown in Fig. 10 . We suggest that under physiological conditions, cytosolic Zn 2ϩ is able to fine-tune the release of Ca 2ϩ from the SR while in parallel enabling flexibility and control of SR Ca 2ϩ dynamics mediated through RyR2. Under pathophysiological conditions, where Zn 2ϩ homeostasis is disturbed and levels of Zn 2ϩ may reach Ͼ1 nM, RyR2 starts to gate in exceptionally long open states, which leads to very high P o potentially leading to arrhythmia. In this conformation, RyR2 is uncoupled from the usual regulatory effects of cytosolic Ca 2ϩ and RyR2 channels are now activated by solely by Zn 2ϩ . Our study reveals that RyR2-mediated Ca 2ϩ homeostasis is intimately related to intracellular Zn 2ϩ levels and provides a mechanistic explanation as to how altered Zn 2ϩ homeostasis can modulate cardiac RyR2 function. We reveal that Zn 2ϩ is a high affinity activator of RyR2 which challenges our understanding of cardiac excitation-contraction coupling. We suggest that under normal physiological conditions, intracellular Zn 2ϩ is essential in fine-tuning the release of Ca 2ϩ from the SR. Pathological perturbations in Zn 2ϩ homoeostasis will lead to inappropriate release of Ca 2ϩ as observed in certain cardiac abnormalities including heart failure and fatal arrhythmias.
Author Contributions-J. W. and R. D. R. performed experiments and analyzed data; A. J. S. designed the experiments and contributed toward writing the manuscript; and S. J. P. designed the experiments, performed experiments, analyzed data, wrote the manuscript, and supervised the project. All authors discussed the results and implications and commented on the manuscript at all stages. release. When 10 M cytosolic Ca 2ϩ is the sole ligand, channel openings are brief, and the channel gates with a low P o . Addition of 1 nM Zn 2ϩ to the cytosolic face of the channel causes an increase in the channel P o , and the channel gates with high frequency openings. In both of these conditions, RyR2 gating is regulated by cytosolic Ca 2ϩ , and lowering the concentration of free Ca 2ϩ to subactivating levels (Ͻ10 nM) reduces RyR2 P o to 0. If the Zn 2ϩ concentration is elevated above 1 nM, RyR2 becomes uncoupled from the usual regulatory effects of cytosolic Ca 2ϩ , and Zn 2ϩ becomes the sole activating ligand.
